GlassScriptPhysician profile
Lynsey C Owen
NPI 1861655342
$2,751.13
in general payments reported to CMS, 2019-2025
31 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $133 · 2021: $407 · 2022: $521 · 2023: $483 · 2024: $398 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.37 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $322.80 | 2019-2025 | |
| Astellas Pharma US INC | $306.58 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $248.35 | 2022-2025 | |
| Organon LLC | $226.68 | 2021-2024 | Nexplanon |
| Renovia INC | $194.87 | 2019 | |
| Abbvie INC. | $174.54 | 2019-2022 | |
| Pfizer INC. | $173.97 | 2019-2024 | |
| Therapeuticsmd, INC. | $148.08 | 2019-2022 | |
| Coopersurgical, INC. | $92.83 | 2019-2024 | Summit Doppler, Endosee |
| Exeltis, USA INC. | $79.56 | 2021-2022 | |
| Molnlycke Health Care US, LLC | $75.22 | 2021 | |
| Exact Sciences Corporation | $73.65 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $67.92 | 2019-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $65.71 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $64.52 | 2022-2024 | Farxiga, Fasenra |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $57.47 | 2021 | |
| Daiichi Sankyo INC. | $54.49 | 2019 | |
| Avion Pharmaceuticals | $51.14 | 2021-2023 | Balcoltra |
| Dynavax Technologies Corporation | $33.33 | 2024-2025 | Heplisav-B |
| Millicent US INC | $32.99 | 2019-2020 | |
| Sage Therapeutics, LLC | $29.54 | 2021-2022 | |
| Shield Therapeutics INC | $28.69 | 2024 | |
| Sumitomo Pharma America, INC. | $23.31 | 2023 | Myfembree |
| Novum Pharma, LLC | $19.52 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.62 | 2020 | |
| Mission Pharmacal Company | $16.42 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.36 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2019 | |
| Ethicon US, LLC | $14.01 | 2023 | Harmonic, Vistaseal, Dermabond Prineo |
| Optumhealth Care Solutions, LLC | $13.70 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Allergan, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynsey Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.